儿童及青少年糖尿病患者迎来重磅利好消息!9月24日,微泰医疗发布公告,Equil®贴敷式胰岛素泵儿童及青少年适应症已于近日获得国家药品监督管理局批准。这使得Equil®贴敷式胰岛素泵在原有成人糖尿病基础上,进一步拓展覆盖了3-17岁儿童及青少年群体。而在Equil®新增适应症过程中,微泰医疗选择通过浙江大学医学院附属儿童医院联合6家全国顶级儿童医院共同完成临床验证,它充分证明了胰岛素泵疗法在儿童及...
Source Link儿童及青少年糖尿病患者迎来重磅利好消息!9月24日,微泰医疗发布公告,Equil®贴敷式胰岛素泵儿童及青少年适应症已于近日获得国家药品监督管理局批准。这使得Equil®贴敷式胰岛素泵在原有成人糖尿病基础上,进一步拓展覆盖了3-17岁儿童及青少年群体。而在Equil®新增适应症过程中,微泰医疗选择通过浙江大学医学院附属儿童医院联合6家全国顶级儿童医院共同完成临床验证,它充分证明了胰岛素泵疗法在儿童及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.